Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA
- PMID: 19914006
- DOI: 10.1016/j.mehy.2009.10.035
Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA
Abstract
Minimized derivatives of bacterial plasmids with removed bacterial backbones are promising vectors for the efficient delivery and for the long-term expression of therapeutic genes. The absence of the bacterial plasmid backbone, a known inducer of innate immune response and a known silencer of transgene expression, provides a partial explanation for the high efficiency of gene transfer using minimized DNA vectors. Supercoiled minicircle DNA is a type of minimized DNA vector obtained via intra-plasmid recombination in bacteria. Minicircle vectors seem to get an additional advantage from their physical compactness, which reduces DNA damage due to the mechanical stress during gene delivery. An independent topological means for DNA compression is knotting, with some knotted DNA isoforms offering superior compactness. I propose that, firstly, knotted DNA can be a suitable compact DNA form for the efficient transfection of a range of human cells with therapeutic genes, and, secondly, that knotted minimized DNA vectors without bacterial backbones ("miniknot" vectors) can surpass supercoiled minicircle DNA vectors in the efficiency of therapeutic gene delivery. Crucially, while the introduction of a single nick to a supercoiled DNA molecule leads to the loss of the compact supercoiled status, the introduction of nicks to knotted DNA does not change knotting. Tight miniknot vectors can be readily produced by the direct action of highly concentrated type II DNA topoisomerase on minicircle DNA or, alternatively, by annealing of the 19-base cohesive ends of the minimized vectors confined within the capsids of Escherichia coli bacteriophage P2 or its satellite bacteriophage P4. After reaching the nucleoplasm of the target cell, the knotted DNA is expected to be unknotted through type II topoisomerase activity and thus to become available for transcription, chromosomal integration or episomal maintenance. The hypothesis can be tested by comparing the gene transfer efficiency achieved with the proposed miniknot vectors, the minicircle vectors described previously, knotted plasmid vectors and standard plasmid vectors. Tightly-wound miniknots can be particularly useful in the gene administration procedures involving considerable forces acting on vector DNA: aerosol inhalation, jet-injection, electroporation, particle bombardment and ultrasound DNA transfer.
(c) 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography.J Gene Med. 2008 Nov;10(11):1253-69. doi: 10.1002/jgm.1243. J Gene Med. 2008. PMID: 18767031
-
A new DNA vehicle for nonviral gene delivery: supercoiled minicircle.Gene Ther. 1997 Dec;4(12):1341-9. doi: 10.1038/sj.gt.3300540. Gene Ther. 1997. PMID: 9472558
-
Transgene expression of transfected supercoiled plasmid DNA concatemers in mammalian cells.J Gene Med. 2009 May;11(5):444-53. doi: 10.1002/jgm.1310. J Gene Med. 2009. PMID: 19263463
-
Use of minicircle plasmids for gene therapy.Methods Mol Biol. 2009;542:87-104. doi: 10.1007/978-1-59745-561-9_4. Methods Mol Biol. 2009. PMID: 19565897 Review.
-
Towards safe, non-viral therapeutic gene expression in humans.Nat Rev Genet. 2005 Apr;6(4):299-310. doi: 10.1038/nrg1577. Nat Rev Genet. 2005. PMID: 15761468 Review.
Cited by
-
Advances in Non-Viral DNA Vectors for Gene Therapy.Genes (Basel). 2017 Feb 10;8(2):65. doi: 10.3390/genes8020065. Genes (Basel). 2017. PMID: 28208635 Free PMC article.
-
Non-viral therapeutic approaches to ocular diseases: An overview and future directions.J Control Release. 2015 Dec 10;219:471-487. doi: 10.1016/j.jconrel.2015.10.007. Epub 2015 Oct 9. J Control Release. 2015. PMID: 26439665 Free PMC article. Review.
-
Construction of pVAX-1-based linear covalently closed vector with improved transgene expression.Mol Biol Rep. 2024 Aug 24;51(1):934. doi: 10.1007/s11033-024-09856-0. Mol Biol Rep. 2024. PMID: 39180671
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical